131 related articles for article (PubMed ID: 38156369)
1. Automated Bioanalytical Workflow for Ligand Binding-Based Pharmacokinetic Assay Development.
Evans BR; Beck AG; Yeung L; Li A; Lee DH; Bateman KP; Chopra G
Anal Chem; 2024 Jan; 96(1):488-495. PubMed ID: 38156369
[TBL] [Abstract][Full Text] [Related]
2. Isolation of human anti-idiotypic antibodies by phage display for clinical immune response assays.
Tornetta M; Fisher D; O'Neil K; Geng D; Schantz A; Brigham-Burke M; Lombardo D; Fink D; Knight D; Sweet R; Tsui P
J Immunol Methods; 2007 Dec; 328(1-2):34-44. PubMed ID: 17888945
[TBL] [Abstract][Full Text] [Related]
3. Critical role of bioanalytical strategies in investigation of clinical PK observations, a Phase I case study.
Peng K; Xu K; Liu L; Hendricks R; Delarosa R; Erickson R; Budha N; Leabman M; Song A; Kaur S; Fischer SK
MAbs; 2014; 6(6):1500-8. PubMed ID: 25484037
[TBL] [Abstract][Full Text] [Related]
4. Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug development.
Mikulskis A; Yeung D; Subramanyam M; Amaravadi L
J Immunol Methods; 2011 Feb; 365(1-2):38-49. PubMed ID: 21130095
[TBL] [Abstract][Full Text] [Related]
5. Screening Non-neutralizing Anti-idiotype Antibodies Against a Drug Candidate for Total Pharmacokinetic and Target Engagement Assay.
Liu V; McGrath K; Albert J; Mayer AP; Busz M; Birchler M; Tang H; Jiang Y
AAPS J; 2024 Jan; 26(1):18. PubMed ID: 38267774
[TBL] [Abstract][Full Text] [Related]
6. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
de Dios K; Manibusan A; Marsden R; Pinkstaff J
J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
[TBL] [Abstract][Full Text] [Related]
7. Optimizing NBE PK/PD assays using the Gyrolab Affinity Software; conveniently within the bioanalyst's existing workflow.
Myzithras M; Bigwarfe T; Waltz E; Li H; Ahlberg J; Rybina I; Low S; Kenny CH; Miglietta J; Kroe-Barrett R
Bioanalysis; 2018 Mar; 10(6):397-406. PubMed ID: 29451404
[TBL] [Abstract][Full Text] [Related]
8. Rapid identification of anti-idiotypic mAbs with high affinity and diverse epitopes by rabbit single B-cell sorting-culture and cloning technology.
Lin W; Liang WC; Nguy T; Maia M; Tyagi T; Chiu C; Hoi KH; Chen Y; Wu Y
PLoS One; 2020; 15(12):e0244158. PubMed ID: 33347473
[TBL] [Abstract][Full Text] [Related]
9. When assay format matters: a case study on the evaluation of three assay formats to support a clinical pharmacokinetic study.
Peng K; Baker D; Brignoli S; Cabuhat J; Fischer SK
AAPS J; 2014 Jul; 16(4):625-33. PubMed ID: 24752719
[TBL] [Abstract][Full Text] [Related]
10. Impact of Shed/Soluble targets on the PK/PD of approved therapeutic monoclonal antibodies.
Samineni D; Girish S; Li C
Expert Rev Clin Pharmacol; 2016 Dec; 9(12):1557-1569. PubMed ID: 27766899
[TBL] [Abstract][Full Text] [Related]
11. Bioanalytical approaches to quantify "total" and "free" therapeutic antibodies and their targets: technical challenges and PK/PD applications over the course of drug development.
Lee JW; Kelley M; King LE; Yang J; Salimi-Moosavi H; Tang MT; Lu JF; Kamerud J; Ahene A; Myler H; Rogers C
AAPS J; 2011 Mar; 13(1):99-110. PubMed ID: 21240643
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a novel semi-homogenous clinical assay for quantitation of Ranibizumab in human serum.
Lowe J; Wakshull E; Shek T; Chuntharapai A; Elliott R; Rusit J; Maia M
J Immunol Methods; 2018 Oct; 461():44-52. PubMed ID: 29772250
[TBL] [Abstract][Full Text] [Related]
13. Development of novel ultra-sensitive IL-11 target engagement assays to support mechanistic PK/PD modeling for an anti-IL-11 antibody therapeutic.
Myzithras M; Lin S; Radden L; Hess Kenny C; Cai Z; MacDonald A; Binetti R; Marlow M; Fracasso P; Gibson G; Bartlett C; Hawkins J; Hansel S
MAbs; 2022; 14(1):2104153. PubMed ID: 35916739
[TBL] [Abstract][Full Text] [Related]
14. A rapid method for generating and characterizing anti-variable region monoclonal antibodies.
Staquet K; Kwok D; Rycyzyn MA; Petley T; Lacy ER; Powers G; Giles-Komar J
Hum Antibodies; 2006; 15(4):155-62. PubMed ID: 17522437
[TBL] [Abstract][Full Text] [Related]
15. Domain-based assays of individual antibody concentrations in an oligoclonal combination targeting a single protein.
Meng Q; Li M; Silberg MA; Conrad F; Bettencourt J; To R; Huang C; Ma J; Meyer K; Shimizu R; Cao L; Tomic MT; Marks JD
Anal Biochem; 2012 Feb; 421(2):351-61. PubMed ID: 22037290
[TBL] [Abstract][Full Text] [Related]
16. Epitope mapping and use of anti-idiotypic antibodies to the L6 monoclonal anticarcinoma antibody.
Hellström KE; Yelton DE; Fell HP; Beaton D; Gayle M; MacLean M; Kahn M; Hellström I
Cancer Res; 1990 Apr; 50(8):2449-54. PubMed ID: 1690598
[TBL] [Abstract][Full Text] [Related]
17. A novel immunoassay to measure total serum lymphotoxin-α levels in the presence of an anti-LTα therapeutic antibody.
Young J; Nguyen A; Qiu ZJ; Ying Y; Gao X; Reed C; Chuntharapai A; Deng R; Lutman J; Grogan J; Wong WL; DeForge L
J Immunol Methods; 2015 Sep; 424():91-9. PubMed ID: 26009247
[TBL] [Abstract][Full Text] [Related]
18. Rapid grouping of monoclonal antibodies based on their topographical epitopes by a label-free competitive immunoassay.
Nagata S; Numata Y; Onda M; Ise T; Hahn Y; Lee B; Pastan I
J Immunol Methods; 2004 Sep; 292(1-2):141-55. PubMed ID: 15350519
[TBL] [Abstract][Full Text] [Related]
19. Bioanalytical platform comparison using a generic human IgG PK assay format.
Leary BA; Lawrence-Henderson R; Mallozzi C; Fernandez Ocaña M; Duriga N; O'Hara DM; Kavosi M; Qu Q; Joyce AP
J Immunol Methods; 2013 Nov; 397(1-2):28-36. PubMed ID: 23994108
[TBL] [Abstract][Full Text] [Related]
20. Development, validation and application of ELISAs for pharmacokinetic and HACA assessment of a chimeric anti-CD40 monoclonal antibody in human serum.
Chowdhury F; Tutt AL; Chan C; Glennie M; Johnson PW
J Immunol Methods; 2010 Dec; 363(1):1-8. PubMed ID: 20869964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
